Megan Murray

Megan Blanche Murray, DPH, MD

Ronda Stryker and William Johnston Professor of Global Health

Phone:

(617) 432-2781

megan_murray@hms.harvard.edu

Tabs

Research

Research Interests

Molecular and genomic epidemiology of MDR and XDR Tuberculosis
The evolution of MDR and XDR tuberculosis
Social determinants of TB risk
Interactions between Tuberculosis and Non-communicable Diseases especially Diabetes Mellitus and iron metabolism disorders
Mathematical modeling of TB and other infectious disease dynamics including SARS and cholera
Methods for evaluating community health programs

Current Projects

Comparative Genomics and Molecular Epidemiology of Tuberculosis
Epidemiology and Transmission Dynamics of MDR/XDR Tuberculosis
TB Drug Resistance Mutation Database
Strengthening and Studying Community-Based Integrated Primary Health Care Systems in Rural Rwanda

Biography

Dr. Murray is professor of global health and social medicine in the Department of Global Health and Social Medicine and associate professor of medicine in the Department of Medicine, Harvard Medical School, and professor of epidemiology at Harvard School of Public Health. Dr. Murray directs the Department of Global Health and Social Medicine Research Core; she is also director of research for the Division of Global Health Equity at Brigham and Women’s Hospital.

Publications

Impact of Vitamin A and Carotenoids on the Risk of Tuberculosis Progression.

Molly Forrest Franke, SD, Jerome T. Galea, Ph.D., Leonid Lecca, M.D., Megan Blanche Murray, DPH, MD

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, September 15, 2017

Aibana O, Franke MF, Huang CC, Galea JT, Calderon R, Zhang Z, Becerra MC, Smith ER, Ronnenberg AG, Contreras C, Yataco R, Lecca L, Murray MB

Link to abstract on PubMed

Prevalence of pyrazinamide resistance and Wayne assay performance analysis in a tuberculosis cohort in Lima, Peru.

Gustavo Eduardo Velasquez, MD, Megan Blanche Murray, DPH, MD, Carole Diane Mitnick, Sc.D.

The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease, August 1, 2017

Calderón RI, Velásquez GE, Becerra MC, Zhang Z, Contreras CC, Yataco RM, Galea JT, Lecca LW, Kritski AL, Murray MB, Mitnick CD

Link to abstract on PubMed

Erratum for Velásquez et al., Pyrazinamide Resistance Assays and Two-Month Sputum Culture Status in Patients with Multidrug-Resistant Tuberculosis.

Carole Diane Mitnick, Sc.D., Mercedes Corina Becerra, Sc.D., Jerome T. Galea, Ph.D., Leonid Lecca, M.D., Megan Blanche Murray, DPH, MD

Antimicrobial agents and chemotherapy, February 23, 2017

Velásquez GE, Calderon RI, Mitnick CD, Becerra MC, Huang CC, Zhang Z, Contreras CC, Yataco RM, Galea JT, Lecca LW, Murray MB

Link to abstract on PubMed

Risk factors for poor multidrug-resistant tuberculosis treatment outcomes in Kyiv Oblast, Ukraine.

Megan Blanche Murray, DPH, MD

BMC infectious diseases, February 7, 2017

Aibana O, Bachmaha M, Krasiuk V, Rybak N, Flanigan TP, Petrenko V, Murray MB

Link to abstract on PubMed

Minimally Symptomatic Infection in an Ebola 'Hotspot': A Cross-Sectional Serosurvey.

Eugene Thomas Richardson, M.D., Ph.D, Megan Blanche Murray, DPH, MD, Paul Edward Farmer, MD, PhD

PLoS neglected tropical diseases, November 15, 2016

Richardson ET, Kelly JD, Barrie MB, Mesman AW, Karku S, Quiwa K, Marsh RH, Koedoyoma S, Daboh F, Barron KP, Grady M, Tucker E, Dierberg KL, Rutherford GW, Barry M, Jones JH, Murray MB, Farmer PE

Link to abstract on PubMed

Nutritional Status and Tuberculosis Risk in Adult and Pediatric Household Contacts.

Jerome T. Galea, Ph.D., Gustavo Eduardo Velasquez, MD, Leonid Lecca, M.D., Megan Blanche Murray, DPH, MD

PloS one, November 11, 2016

Aibana O, Acharya X, Huang CC, Becerra MC, Galea JT, Chiang SS, Contreras C, Calderon R, Yataco R, Velásquez GE, Tintaya K, Jimenez J, Lecca L, Murray MB

Link to abstract on PubMed

Pyrazinamide Resistance Assays and Two-Month Sputum Culture Status in Patients with Multidrug-Resistant Tuberculosis.

Gustavo Eduardo Velasquez, MD, Carole Diane Mitnick, Sc.D., Mercedes Corina Becerra, Sc.D., Jerome T. Galea, Ph.D., Leonid Lecca, M.D., Megan Blanche Murray, DPH, MD

Antimicrobial agents and chemotherapy, October 21, 2016

Velásquez GE, Calderon RI, Mitnick CD, Becerra MC, Huang CC, Zhang Z, Contreras CC, Yataco RM, Galea JT, Lecca LW, Murray MB

Link to abstract on PubMed

Novel Ordered Stepped-Wedge Cluster Trial Designs for Detecting Ebola Vaccine Efficacy Using a Spatially Structured Mathematical Model.

Gustavo Eduardo Velasquez, MD, Megan Blanche Murray, DPH, MD

PLoS neglected tropical diseases, August 10, 2016

Diakite I, Mooring EQ, Velásquez GE, Murray MB

Link to abstract on PubMed

Rifampin Resistance Mutations Are Associated with Broad Chemical Remodeling of Mycobacterium tuberculosis.

Megan Blanche Murray, DPH, MD

The Journal of biological chemistry, May 10, 2016

Lahiri N, Shah RR, Layre E, Young D, Ford C, Murray MB, Fortune SM, Moody DB

Link to abstract on PubMed

Management and control of multidrug-resistant tuberculosis (MDR-TB): Addressing policy needs for India.

Megan Blanche Murray, DPH, MD

Journal of public health policy, May 6, 2016

Atre SR, Murray MB

Link to abstract on PubMed

1
2
3
4
5
6
7
8
9
…
next ›
last »

Affiliations

Professor, Department of Epidemiology, Harvard School of Public Health Associate Professor, Department of Medicine, Brigham and Women’s Hospital Associate member, Broad Institute

Contact

Address:

Department of Global Health and Social Medicine

641 Huntington Avenue

Boston, MA 02115

Alternative email address: mmurray@hsph.harvard.edu

Faculty

Affiliates

Visiting Scholars

Postdoctoral Fellows

Administrative staff

Tabs

Impact of Vitamin A and Carotenoids on the Risk of Tuberculosis Progression.

Prevalence of pyrazinamide resistance and Wayne assay performance analysis in a tuberculosis cohort in Lima, Peru.

Erratum for Velásquez et al., Pyrazinamide Resistance Assays and Two-Month Sputum Culture Status in Patients with Multidrug-Resistant Tuberculosis.

Risk factors for poor multidrug-resistant tuberculosis treatment outcomes in Kyiv Oblast, Ukraine.

Minimally Symptomatic Infection in an Ebola 'Hotspot': A Cross-Sectional Serosurvey.

Nutritional Status and Tuberculosis Risk in Adult and Pediatric Household Contacts.

Pyrazinamide Resistance Assays and Two-Month Sputum Culture Status in Patients with Multidrug-Resistant Tuberculosis.

Novel Ordered Stepped-Wedge Cluster Trial Designs for Detecting Ebola Vaccine Efficacy Using a Spatially Structured Mathematical Model.

Rifampin Resistance Mutations Are Associated with Broad Chemical Remodeling of Mycobacterium tuberculosis.

Management and control of multidrug-resistant tuberculosis (MDR-TB): Addressing policy needs for India.